{
  "abstract": "Delirium is an acute impairment of consciousness characterised by a disturbance in attention and sleep-wake cycle. Delirium is frequently observed in patients with cancer and is associated with increased mortality and morbidity, elevated distress of patients and family, prolonged hospital stays and additional medical costs. Therefore, interventions aimed at preventing delirium are of clinical significance.",
  "authors": [
    {
      "affiliations": [
        "Department of Pharmacy, Institute of Science Tokyo Hospital, Tokyo, Japan"
      ],
      "name": "Shuntaro Yasuda"
    },
    {
      "affiliations": [
        "Department of Psychosomatic Medicine, Faculty of Medicine, University of Tokyo Hospital, Tokyo, Japan"
      ],
      "name": "Saki Harashima"
    },
    {
      "affiliations": [
        "Department of Psychosomatic Internal Medicine, NHO Kinki Chuo Chest Medical Center, Sakai, Japan"
      ],
      "name": "Yoshinobu Matsuda"
    },
    {
      "affiliations": [
        "Department of Nursing, Niimi University, Niimi, Okayama, Japan"
      ],
      "name": "Shinichiro Inoue"
    },
    {
      "affiliations": [
        "Graduate School of Nursing, Nagoya City University, Mizuho-ku, Aichi, Japan"
      ],
      "name": "Hitoshi Tanimukai"
    },
    {
      "affiliations": [
        "Division of Quality Assurance Programs, National Cancer Center Institute for Cancer Control, Tokyo, Japan"
      ],
      "name": "Saho Wada"
    },
    {
      "affiliations": [
        "Graduate School of Medicine, Mie University, Tsu, Mie, Japan"
      ],
      "name": "Jun Kako"
    },
    {
      "affiliations": [
        "Center for Psycho-oncology and Palliative Care, Nagoya City University Hospital, Nagoya, Japan"
      ],
      "name": "Takaaki Hasegawa"
    }
  ],
  "title": "Orexin receptor antagonists for delirium prevention: systematic review in cancer",
  "uid": "c331b9f5-9c79-5606-ba60-cfdcc09bd43d"
}